Aethlon Medical (AEMD)
(Delayed Data from NSDQ)
$0.42 USD
-0.02 (-4.09%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $0.40 -0.02 (-3.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Aethlon Medical, Inc. [AEMD]
Reports for Purchase
Showing records 1 - 20 ( 76 total )
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Hemopurifier Set to Advance Into Evaluation for Oncology Use; Reiterate Buy With New $7 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Expecting Combination of Hemopurifier With Santersus Devices to Yield Positive Results; Reit. Buy; Adjusted PT of $10
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Hemopurifier Study Ready to Advance Into the Oncology Setting: Reit. Buy Rating With New Reverse Split-Adjusted $23 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
NAMSA Contract to Accelerate Hemopurifier Advancement in Cancer; Reiterate Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Hemopurifier Shows Potential For Clearing Monkeypox Virus; Reiterate Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Hemopurifier Programs Continue to Make Progress; Reiterate Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Hemopurifier Trial Conditions Look Favorable With COVID-19 Cases Surging Again
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Interest in Evaluating Hemopurifier Grows as Delta Variant Cases Grow; Reiterate Buy and $9 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
COVID-19 Feasibility Study Poised to Open Enrollment; Reiterate Buy With our PT Adjusted to $9 from $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
We initiate coverage on shares with a Buy rating and price target of $5
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
We are hereby terminating our coverage due to reallocation of resources within the research department.
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Company: Aethlon Medical, Inc.
Industry: Medical - HMOs
Fiscal 3Q19 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R